Form 4: Fulgent Genetics' Chief Scientific Officer Sells Shares to Cover Tax Obligations
SEC Form 4
Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, sold 563 shares of common stock on August 27, 2024, to satisfy tax withholding obligations related to vesting restricted stock units.
Summary
- On August 27, 2024, Hanlin Gao, the Chief Scientific Officer of Fulgent Genetics, sold 563 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations arising from the vesting of restricted stock units granted on February 23, 2023.
- The shares were sold at prices ranging from $22.72 to $22.915, with a weighted-average sale price of $22.833.
- Following the transaction, Gao directly owns 924,560 shares of Fulgent Genetics' common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction related to tax obligations, not indicative of a major positive or negative event.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It doesn't necessarily reflect a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| February 23, 2023 | Date of restricted stock unit grant to Hanlin Gao. |
| February 27, 2023 | Original Form 4 filing date for the restricted stock unit grant. |
| August 27, 2024 | Date of stock sale by Hanlin Gao. |
| August 29, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.